SLC5A2 and Ventricular arrhythmia: We do not know of any other reports of the effect of SGLT2 inhibitors on ventricular arrhythmias in this patient group, although empagliflozin has been shown to reduce the incidence of VF related to ischaemia/reperfusion in Langendorff-perfused rabbit hearts.31